Anticoagulant-related bleeding in patients with heart failure in combination with chronic obstructive pulmonary disease and atrial fibrillation. Experience with Idarucizumab

Aim. To study the characteristics of direct oral anticoagulant-related bleeding in patients with heart failure in combination with chronic obstructive pulmonary disease (COPD) and atrial fibrillation. To show the efficacy of idarucizumab in complex therapy of severe gastrointestinal bleeding caused...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	L. A. Shpagina, O. S. Kotova, I. S. Shpagin, E. M. Loktin, A. A. Rukavitsyna, T. S. Flyagin, T. M. Smarzh, N. V. Kamneva, D. A. Gerasimenko, E. V. Anikina, A. V. Ponomareva
Aineistotyyppi:	Artigo
Kieli:	Russo
Julkaistu:	«FIRMA «SILICEA» LLC 2020-06-01
Sarja:	Российский кардиологический журнал
Aiheet:	direct oral anticoagulants bleeding idarucizumab
Linkit:	https://russjcardiol.elpub.ru/jour/article/view/3921
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!